Thema
Phase I study
Pharmacokinetics
7
Japanese patients
6
Solid tumors
6
Immune checkpoint inhibitor
4
Nivolumab
4
AZD2171
3
Anti-microtubule
3
BMS-247550
3
Carboplatin
3
Cediranib
3
Dose escalation
3
EGFR
3
Epothilone B analog
3
Erlotinib
3
Gemcitabine prodrug
3
Interstitial pneumonitis
3
Ipilimumab
3
Ixabepilone
3
Japanease
3
Lung cancer
3
MAPK pathway
3
MEK inhibitor
3
MET
3
Non-small-cell lung cancer
3
Onartuzumab
3
Paclitaxel
3
Pharmacogenetics
3
Pharmacokinetic
3
Ridaforolimus
3
Ro50-8231
3
Stomatitis
3
Tarceva
3
Tolerability
3
Tyrosine kinase inhibitor
3
Vascular endothelial growth factor receptor
3
mTOR inhibitor
3
31YO63LBSN
1
Antibodies, Monoclonal
1
Antineoplastic Agents
1
Clinical Trial, Phase I
1
Journal Article
1
PDCD1 protein, human
1
Programmed Cell Death 1 Receptor
1